GTS Securities’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,479
| Closed | -$55.8K | – | 1221 |
|
|
2024
Q3 | $55.8K | Buy |
21,479
+3,124
| +17% | +$8.12K | ﹤0.01% | 1604 |
|
|
2024
Q2 | $54.3K | Sell |
18,355
-9,085
| -33% | -$26.9K | ﹤0.01% | 1459 |
|
|
2024
Q1 | $124K | Sell |
27,440
-4,308
| -14% | -$19.5K | ﹤0.01% | 1255 |
|
|
2023
Q4 | $181K | Buy |
31,748
+15,605
| +97% | +$89.1K | ﹤0.01% | 1343 |
|
|
2023
Q3 | $74.3K | Buy |
+16,143
| New | +$74.3K | ﹤0.01% | 1252 |
|